1. Home
  2. FCF vs DAWN Comparison

FCF vs DAWN Comparison

Compare FCF & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Commonwealth Financial Corporation

FCF

First Commonwealth Financial Corporation

HOLD

Current Price

$18.83

Market Cap

1.9B

Sector

Finance

ML Signal

HOLD

Logo Day One Biopharmaceuticals Inc.

DAWN

Day One Biopharmaceuticals Inc.

HOLD

Current Price

$21.48

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FCF
DAWN
Founded
1934
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
2.2B
IPO Year
1994
2021

Fundamental Metrics

Financial Performance
Metric
FCF
DAWN
Price
$18.83
$21.48
Analyst Decision
Buy
Buy
Analyst Count
4
8
Target Price
$19.75
$24.43
AVG Volume (30 Days)
708.9K
1.5M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
2.87%
N/A
EPS Growth
5.76
N/A
EPS
1.47
N/A
Revenue
N/A
$158,182,000.00
Revenue This Year
$16.32
$55.03
Revenue Next Year
$6.25
$28.12
P/E Ratio
$12.80
N/A
Revenue Growth
N/A
20.60
52 Week Low
$14.31
$5.64
52 Week High
$19.14
$21.50

Technical Indicators

Market Signals
Indicator
FCF
DAWN
Relative Strength Index (RSI) 68.11 79.82
Support Level $16.28 $10.30
Resistance Level $19.02 $21.50
Average True Range (ATR) 0.33 0.03
MACD 0.08 -0.31
Stochastic Oscillator 82.30 77.78

Price Performance

Historical Comparison
FCF
DAWN

About FCF First Commonwealth Financial Corporation

First Commonwealth Financial Corp functions in the financial services sector in the United States. Through its subsidiary, it offers a range of consumer and commercial banking services such as personal checking accounts, interest-earning checking accounts, savings accounts, insured money market accounts, investment certificates, fixed & variable rate certificates of deposit, and various kinds of loans. It also provides trust and wealth management services and offers insurance products. The company earns the majority of its revenue through net interest income.

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY301 is an antibody drug conjugate (ADC) that has shown antitumor activity in preclinical models.

Share on Social Networks: